The challenges posed by COVID-19 transcend international borders and require global solutions. This includes addressing the potential for substandard and falsified (SSF) COVID-19 vaccines, particularly in low- and middle-income countries. At the U.S.
While the global vaccination effort to curb the spread of COVID-19 continues to ramp up worldwide, access to COVID-19 vaccines, particularly in low- and middle-income countries, remains staggeringly low. In fact, low- and middle-income countries received less than one percent of available doses.
USP’s success in its mission to improve global public health through creation of standards and related programs depends in large part on the work of volunteers.
In simple terms, risk is the possibility of something bad happening. It’s the uncertainty around the consequences of an activity with respect to something that we value.
USP’s recently released COVID-19 Vaccine Handling Toolkit is helping to fill critical operational efficiency gaps that practice settings have identified in vaccine administration.